bmi 25 glp 1 Products - Data Briefs - Number 537 Does a patient with pre-diabetes

The study was published in JACC: Clinical Electrophysiology and presented at the American College of Cardiology Scientific Session.

Read the Bloomberg article here...

Glucagon-like peptide-1 (GLP-1) receptor agonists have been used extensively in the clinic and have an established safety profile in cardiovascular disease settings

While GLP-1 agonist therapy medications have been marketed as diabetes treatments before, Mounjaro also has the action of glucose-dependent insulinotropic polypeptide (GIP)

My Life On GLP-1: The Honest, Hilarious, & Gassy Truth About Losing Weight and Finding Myself

On reflection, we come to realize that Scott Galloways observation about the drug category profoundly impacting society and the macro-economy was spot-on and prescient.